The Effect of Acute Interpersonal Racial Discrimination on Smoking Motivation and Behavior Among Black Smokers: an Experimental Study.

Journal of Racial and Ethnic Health Disparities
Patricia F Calixte-Civil, Thomas H Brandon

Abstract

In comparison to White smokers, Black smokers are likely to report both more discrimination and less success in smoking cessation. No previous study has tested the causal relationship between an experience of racial discrimination and smoking variables associated with cessation. The goal of this study was to test the causal influence of interpersonal racial discrimination on smoking motivation (i.e., the urge to smoke cigarettes, cessation self-efficacy, and smoking behavior) using a controlled experimental design. We used a virtual ball-playing game to create a laboratory model of racial discrimination. A 2 × 2 between-subjects factorial design (inclusion/exclusion vs. ingroup/outgroup) was used to randomly assign participants to one of four groups: (1) included/ingroup, (2) included/outgroup, (3) excluded/ingroup (ostracism), and (4) excluded/outgroup (racial discrimination). Sixty-nine Black smokers were recruited from the community. Participants in the excluded conditions reported lower cessation self-efficacy than those in the included conditions. Participants in the outgroup conditions had reduced latency to smoke compared to those in the ingroup conditions. There were no main effects of social inclusion on cravings or la...Continue Reading

References

Sep 1, 1991·British Journal of Addiction·T F HeathertonK O Fagerström
Jan 1, 1986·Health Education Quarterly·V J StrecherI M Rosenstock
Sep 26, 2000·Addiction·M A SayetteW G Shadel
Nov 18, 2000·Journal of Personality and Social Psychology·K D WilliamsW Choi
Feb 15, 2001·Addiction·B T JonesK Fromme
Mar 22, 2001·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·L S CoxA G Christen
Mar 22, 2001·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·K S OkuyemiK Resnicow
Jan 29, 2002·International Immunopharmacology·Eric V Yang, Ronald Glaser
Mar 12, 2002·JAMA : the Journal of the American Medical Association·Eric C SchneiderArnold M Epstein
Aug 8, 2002·Journal of Women's Health & Gender-based Medicine·Jennifer M WatsonBettina M Beech
Jan 30, 2003·American Journal of Public Health·David R WilliamsJames S Jackson
Feb 18, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jean-François EtterThomas V Perneger
May 22, 2003·Journal of Personality and Social Psychology·Robert M Sellers, J Nicole Shelton
Jan 31, 2004·American Journal of Preventive Medicine·Dennis R TrinidadJohn P Pierce
Feb 6, 2004·Psychological Review·Timothy B BakerMichael C Fiore
Apr 7, 2004·Journal of Consulting and Clinical Psychology·Saul Shiffman, Andrew J Waters
Sep 25, 2007·Brain, Behavior, and Immunity·Margaret E Kemeny, Manfred Schedlowski
Nov 21, 2007·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Laura Smart RichmanRedford B Williams
Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Jonathan P Godbout, Ronald Glaser
Jan 12, 2008·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Sharon S AllenBruce Center
May 21, 2008·Journal of Abnormal Psychology·Joseph W Ditre, Thomas H Brandon
Aug 22, 2008·Journal of Substance Abuse Treatment·Stuart G Ferguson, Saul Shiffman
Feb 28, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Dennis R TrinidadKaren S Messer
Jul 10, 2009·Psychological Bulletin·Elizabeth A Pascoe, Laura Smart Richman
Feb 18, 2010·Experimental and Clinical Psychopharmacology·Erika B Litvin, Thomas H Brandon
Feb 19, 2010·The American Journal on Addictions·Brian L CarterPaul M Cinciripini
Feb 24, 2011·Experimental and Clinical Psychopharmacology·Jason D RobinsonPaul M Cinciripini
May 14, 2011·American Journal of Public Health·David T LevyDavid B Abrams
Jul 23, 2011·American Journal of Public Health·Nancy KriegerKarestan Koenen
Dec 22, 2012·Psychological Science·Jeremy P JamiesonWendy Berry Mendes
May 8, 2013·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Michelle L StockMeg Gerrard
Jun 26, 2013·Addiction·Bryan W HeckmanThomas H Brandon
Nov 20, 2014·Stress : the International Journal on the Biology of Stress·Maximus Berger, Zoltán Sarnyai
Mar 3, 2015·Experimental and Clinical Psychopharmacology·Cynthia A ConklinCraig S Parzynski
May 30, 2015·PloS One·Chris H J HartgerinkKipling D Williams
Jul 17, 2015·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Cendrine D RobinsonAndrew J Waters
Nov 12, 2015·Journal of Smoking Cessation·Carrie A BronarsLisa Sanderson Cox
Dec 19, 2016·American Journal of Preventive Medicine·Irena Stepanikova, Gabriela R Oates

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.